What does LIFE - CARE do?

LIFE - CARE is a healthcare practice in Gent. Private Limited, started on 12 January 1996, 1 establishment.

What is the address of LIFE - CARE?

The registered office of LIFE - CARE is located at Steenvoordelaan 56, 9050 Gent.

Is LIFE - CARE still active?

Yes. According to the CBE (31 October 2026) LIFE - CARE is active, legal situation “Normale toestand”, started on 12 January 1996.

Is LIFE - CARE registered on Peppol?

Yes, LIFE - CARE is registered on the Peppol network with ID 0208:0456971651.

What is the enterprise number of LIFE - CARE?

The enterprise number of LIFE - CARE is BE0456971651.

When was LIFE - CARE founded?

LIFE - CARE was founded on 12 January 1996.

Who are the directors of LIFE - CARE?

According to the 2025 annual accounts, the directors of LIFE - CARE are: ELLOMAR BV.

Is LIFE - CARE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 January 1996; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did LIFE - CARE make in 2025?

LIFE - CARE posted a profit after taxes of € 252,172 in financial year 2025.

What is the revenue of LIFE - CARE?

As a small company, LIFE - CARE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 2,025,421.

How much does an employee at LIFE - CARE earn?

The average wage cost per full-time employee at LIFE - CARE was € 43,600 in 2025: staff costs of € 1.4 million for 32.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does LIFE - CARE have?

According to the 2025 annual accounts, LIFE - CARE has 32.1 full-time equivalents (FTE).

LIFE - CARE (Private Limited) - Gent - BE0456971651

Dossier LIFE - CARE, printed on 1 November 2026 from databakkes.be/en/0456971651/life-care. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

LIFE - CARE from Gent, company number BE0456971651, closed financial year 2025 with a result of € 252,172 after tax. For that financial year LIFE - CARE recorded a gross margin of € 2 million and equity of € 715,257. Compared with financial year 2024, the result moved from € 76,006 to € 252,172. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.

What it is worth Healthy

€ 715,257

▼ 28% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 252,172

▲ 232% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 681,813

▲ 273% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 533,880 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

32.1

▲ 8.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 1.4 million

▲ 45% vs 2024

€ 43,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 473,936

Of which on lease € 46,850.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 345,062

€ 128,937 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 345,080

▲ 85% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 103,584

▲ 45% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 730,792 Gross margin 2022: € 730,792 First fiscal year in the series	€ 952,579 Gross margin 2023: € 952,579 ▲ 30% vs 2022 (€ 730,792) Favourable step	€ 1,331,172 Gross margin 2024: € 1,331,172 ▲ 40% vs 2023 (€ 952,579) Favourable step	€ 2,025,421 Gross margin 2025: € 2,025,421 ▲ 52% vs 2024 (€ 1,331,172) Favourable step	▲ 52%
Profit after taxes	€ 191,934 Profit after taxes 2022: € 191,934 First fiscal year in the series	€ 169,618 Profit after taxes 2023: € 169,618 ▼ 12% vs 2022 (€ 191,934) Unfavourable step	€ 76,006 Profit after taxes 2024: € 76,006 ▼ 55% vs 2023 (€ 169,618) Unfavourable step	€ 252,172 Profit after taxes 2025: € 252,172 ▲ 232% vs 2024 (€ 76,006) Favourable step	▲ 232%
Equity	€ 754,726 Equity 2022: € 754,726 First fiscal year in the series	€ 922,678 Equity 2023: € 922,678 ▲ 22% vs 2022 (€ 754,726) Favourable step	€ 996,965 Equity 2024: € 996,965 ▲ 8% vs 2023 (€ 922,678) Favourable step	€ 715,257 Equity 2025: € 715,257 ▼ 28% vs 2024 (€ 996,965) Unfavourable step	▼ 28%
Total debts	€ 280,596 Total debts 2022: € 280,596 First fiscal year in the series	€ 544,625 Total debts 2023: € 544,625 ▲ 94% vs 2022 (€ 280,596) Unfavourable step	€ 612,669 Total debts 2024: € 612,669 ▲ 12% vs 2023 (€ 544,625) Unfavourable step	€ 1,302,376 Total debts 2025: € 1,302,376 ▲ 113% vs 2024 (€ 612,669) Unfavourable step	▲ 113%
Cash	€ 210,760 Cash 2022: € 210,760 First fiscal year in the series	€ 244,440 Cash 2023: € 244,440 ▲ 16% vs 2022 (€ 210,760) Favourable step	€ 182,968 Cash 2024: € 182,968 ▼ 25% vs 2023 (€ 244,440) Unfavourable step	€ 681,813 Cash 2025: € 681,813 ▲ 273% vs 2024 (€ 182,968) Favourable step	▲ 273%
Retained profit	€ 722,500 Retained profit 2022: € 722,500 First fiscal year in the series	€ 890,452 Retained profit 2023: € 890,452 ▲ 23% vs 2022 (€ 722,500) Favourable step	€ 964,739 Retained profit 2024: € 964,739 ▲ 8% vs 2023 (€ 890,452) Favourable step	€ 683,031 Retained profit 2025: € 683,031 ▼ 29% vs 2024 (€ 964,739) Unfavourable step	▼ 29%
Dividend	€ 1,600 Dividend 2022: € 1,600 First fiscal year in the series	€ 1,666 Dividend 2023: € 1,666 ▲ 4% vs 2022 (€ 1,600) Unchanged	€ 1,718 Dividend 2024: € 1,718 ▲ 3% vs 2023 (€ 1,666) Unchanged	€ 533,880 Dividend 2025: € 533,880 ▲ € 532,162 vs 2024 (€ 1,718) Unchanged	▲ € 532,162
Bank debt	€ 162,613 Bank debt 2022: € 162,613 First fiscal year in the series	€ 310,353 Bank debt 2023: € 310,353 ▲ 91% vs 2022 (€ 162,613) Unfavourable step	€ 344,676 Bank debt 2024: € 344,676 ▲ 11% vs 2023 (€ 310,353) Unfavourable step	€ 345,062 Bank debt 2025: € 345,062 Unchanged (€ 344,676) Unfavourable step
Balance sheet total	€ 1,035,321 Balance sheet total 2022: € 1,035,321 First fiscal year in the series	€ 1,467,303 Balance sheet total 2023: € 1,467,303 ▲ 42% vs 2022 (€ 1,035,321) Unchanged	€ 1,609,634 Balance sheet total 2024: € 1,609,634 ▲ 10% vs 2023 (€ 1,467,303) Unchanged	€ 2,017,633 Balance sheet total 2025: € 2,017,633 ▲ 25% vs 2024 (€ 1,609,634) Unchanged	▲ 25%
Employees (FTE)	11.4 Employees (FTE) 2022: 11.4 First fiscal year in the series	15.1 Employees (FTE) 2023: 15.1 ▲ 3.7 vs 2022 (11.4) Unchanged	23.7 Employees (FTE) 2024: 23.7 ▲ 8.6 vs 2023 (15.1) Unchanged	32.1 Employees (FTE) 2025: 32.1 ▲ 8.4 vs 2024 (23.7) Unchanged	▲ 8.4

Key figures of LIFE - CARE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to LIFE - CARE?

What happened at LIFE - CARE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 24, 2026 New annual accounts for financial year 2025: profit of € 252,172 (▲ 232% vs 2024). Source: NBB ↗
2025 ELLOMAR BV became a director. NBB
Feb 9, 1996 New establishment in Gent. KBO
Jan 12, 1996 Start of the company according to the CBE. KBO

In short

From € 191,934 profit in 2022 to € 252,172 profit in 2025.

Paid € 285,645 in corporate taxes since 2022.

Best year ever: 2025, with € 252,172 profit.

On average € 63,100 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Ellomar 100%

The stake of Ellomar comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

LIFE - CARE

Behind LIFE - CARE is ELLOMAR BV. The shares are held by Ellomar (100%).

Directors

According to the 2025 annual accounts

ELLOMAR BV

Director · represented by CELINE VANDEVYVER

Also active at: 112 Hageland, MEDICS AT HOME, Care Estate

since 2025

Shareholders

Ellomar

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Steenvoordelaan 56

9050 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.

All companies at this address →

UNIE VOOR DE BELGISCHE AMBULANCESECTOR

112 Hageland same network

€ 871,580 gross margin · 2025

LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING

€ 173,478 gross margin · 2025

MEDICS AT HOME same network

€ 931,401 gross margin · 2025

BTW GROEP LIFE-CARE

+2 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0456.971.651

VAT number

BE 0456.971.651

Registered office

Steenvoordelaan 56, 9050 Gent

Names & denominations

LIFE - CARE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

12 January 1996

Peppol

Active · Active since 21 Oct 2026

Activities · NACE

Patiëntenvervoer per ambulance

Ziekenvervoer

Overige vormen van onderwijs

Overige activiteiten op het gebied van menselijke gezondheidszorg, neg

Diensten voor personenvervoer op aanvraag per voertuig met chauffeur

View on CBE Public ↗ Annual accounts (NBB) ↗

LIFE - CARE

Financials

What happened to LIFE - CARE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions